Skip to content
healthcare.dev

Acetazolamide

NDC 70954-034, Acetazolamide, tablet, from ANI Pharmaceuticals, Inc..

Product NDC
70954-034
Status
Listed
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210588
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70954-034 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAZOLAMIDE250 mg/1

Pharmacologic classes

Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]

Package NDCNDC-11Package
70954-034-20709540034201000 TABLET in 1 BOTTLE (70954-034-20)
70954-034-3070954003430100 TABLET in 1 BOTTLE (70954-034-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bde94a48-05d0-45a0-a589-ec05b7d16532
  • NADAC price for package 70954003430

    GET /v1/drugs/nadac/70954003430

Use it

Look up 70954-034 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70954-034 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70954-034. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.